BSE filing, NSE: JSLL. Summary written from the filing by ALFA Finder's alert engine.
Jeena Sikho Lifecare Ltd: key numbers
- Share price
- ₹347.80
- Market cap
- ₹4,324 Cr
- Revenue (annual)
- ₹801.4 Cr
- Net profit (annual)
- ₹221.8 Cr
- P/E (TTM)
- 18.3×Sector 46.5×
- Promoter holding
- 63.67%+0.05% QoQ
- FII holding
- 4.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jeena Sikho Lifecare Ltd
All →Jeena Sikho Lifecare Employee Stock Options
Jeena Sikho Lifecare allotted 23,374 equity shares under its ESOS 2024 scheme. This allotment increases the company's total paid-up equity share capital.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare Limited has launched eight new Ayurvedic healthcare, wellness, and nutraceutical products. These new offerings are now available in the domestic market.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare received NABH accreditation for its hospital in Raipur, Chhattisgarh, signifying adherence to quality healthcare and patient safety standards.
Jeena Sikho Lifecare Promoter Buying
Bhavna Grover, a promoter of Jeena Sikho Lifecare Limited, acquired 35,000 equity shares via open market purchase. This transaction increased the total promoter group stake from 63.62% to 63.64%.
- Promoter stake change
- +0.02%
Jeena Sikho Lifecare Annual General Meeting
Jeena Sikho Lifecare Limited held its 9th Annual General Meeting on September 28, 2026, transacting ordinary and special business items, including dividend declaration and director appointments.
Jeena Sikho Lifecare Employee Stock Options
Jeena Sikho Lifecare received BSE in-principle approval to list up to 6,50,000 ESOS 2024 shares. Both NSE and BSE approvals are now in place.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.